Clinical Trials Browser

NETWORK × Standard of Care × Tumor-Agnostic × Clear all

NCT05455606 2026-01-22

Does the Use of a Genomic Tumor Board Increase the Number of Patients Who Receive Genome-Informed Treatment

Phase NA Active not recruiting

Neoplasm Metastasis